When.com Web Search

  1. Ads

    related to: donepezil for lewy body

Search results

  1. Results From The WOW.Com Content Network
  2. Donepezil - Wikipedia

    en.wikipedia.org/wiki/Donepezil

    Donepezil has been tested in other cognitive disorders, including Lewy body dementia, [33] and vascular dementia, [34] but it is not currently approved for these indications. Donepezil has also been found to improve sleep apnea in people with Alzheimer's. [35] It also improves gait in people with mild Alzheimer's. [36]

  3. Dementia with Lewy bodies - Wikipedia

    en.wikipedia.org/wiki/Dementia_with_Lewy_bodies

    People with Lewy body dementias who take neuroleptics are at risk for neuroleptic malignant syndrome, a life-threatening illness. [51] There is no evidence to support the use of antipsychotics to treat the Lewy body dementias, [10] and they carry the additional risk of stroke when used in the elderly with dementia. [86]

  4. The first treatment was a cholinesterase inhibitor called donepezil, ... “I’ve seen them help many of my Lewy body patients and in some cases they seem even more helpful than in Alzheimer’s ...

  5. Category:Lewy body dementia - Wikipedia

    en.wikipedia.org/wiki/Category:Lewy_body_dementia

    Pages in category "Lewy body dementia" ... Dementia with Lewy Bodies Consortium; Donepezil; K. Kenji Kosaka (psychiatrist) L. Lewy body; Lewy Body Dementia Association;

  6. Lewy body dementia - Wikipedia

    en.wikipedia.org/wiki/Lewy_body_dementia

    Lewy body dementia (LBD) is an umbrella term for two similar and common subtypes of dementia: [1] dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD).

  7. Cholinesterase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Cholinesterase_inhibitor

    Paraoxon and rivastigmine are both acetylcholinesterase inhibitors and butyrylcholinesterase inhibitors. [14] [11] [7]In 2015, the United States Food and Drug Administration's Adverse Event Reporting System database compared rivastigmine to the other ChEI drugs donepezil and galantamine found that rivastigmine was associated with a higher frequency of reports of death as an adverse event.